Grifols SA (GRFS)
7.30
-0.20
(-2.67%)
USD |
NASDAQ |
Oct 08, 12:30
Grifols Market Cap : 1.885B for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 1.937B |
| October 06, 2026 | 1.942B |
| October 05, 2026 | 1.913B |
| October 02, 2026 | 1.888B |
| October 01, 2026 | 1.885B |
| September 30, 2026 | 1.888B |
| September 29, 2026 | 1.884B |
| September 28, 2026 | 1.913B |
| September 25, 2026 | 1.898B |
| September 24, 2026 | 1.859B |
| September 23, 2026 | 1.858B |
| September 22, 2026 | 1.921B |
| September 21, 2026 | 1.901B |
| September 18, 2026 | 1.888B |
| September 17, 2026 | 1.911B |
| September 16, 2026 | 1.911B |
| September 15, 2026 | 1.901B |
| September 14, 2026 | 1.932B |
| September 11, 2026 | 1.950B |
| September 10, 2026 | 1.975B |
| September 09, 2026 | 2.019B |
| September 08, 2026 | 2.001B |
| September 04, 2026 | 2.014B |
| September 03, 2026 | 2.035B |
| September 02, 2026 | 2.022B |
| Date | Value |
|---|---|
| September 01, 2026 | 1.996B |
| August 31, 2026 | 1.993B |
| August 28, 2026 | 1.986B |
| August 27, 2026 | 2.019B |
| August 26, 2026 | 2.040B |
| August 25, 2026 | 2.089B |
| August 24, 2026 | 2.063B |
| August 21, 2026 | 2.066B |
| August 20, 2026 | 2.063B |
| August 19, 2026 | 2.130B |
| August 18, 2026 | 2.001B |
| August 17, 2026 | 2.006B |
| August 14, 2026 | 2.009B |
| August 13, 2026 | 2.048B |
| August 12, 2026 | 2.048B |
| August 11, 2026 | 2.063B |
| August 10, 2026 | 2.079B |
| August 07, 2026 | 2.050B |
| August 06, 2026 | 2.022B |
| August 05, 2026 | 2.048B |
| August 04, 2026 | 2.084B |
| August 03, 2026 | 2.030B |
| July 31, 2026 | 2.032B |
| July 30, 2026 | 2.117B |
| July 29, 2026 | 2.105B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| argenx SE | 50.15B |
| Evaxion AS | 25.90M |
| Akari Therapeutics Plc | 14.97M |
| Pharma Mar SA | 1.640B |
| Oryzon Genomics SA | 240.11M |
Market Cap Related Metrics
| PE Ratio | 9.421 |
| PS Ratio | 0.5739 |
| PEG Ratio | 0.1527 |
| Price to Book Value | 0.7835 |
| Price to Free Cash Flow | 6.723 |
| Price | 7.30 |
| Earnings Yield | 10.62% |
| PEGY Ratio | 0.1440 |
| Operating PE Ratio | 3.536 |
| Normalized PE Ratio | 9.421 |